Acadian Asset Management
ARNA

Acadian Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Acadian Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-51,546
Closed -$3.25M – 2438
2020
Q2 		$3.25M Buy
+51,546
New +$2.84M 0.01% 589
2019
Q4 		– Sell
-297,426
Closed -$13.6M – 2136
2019
Q3 		$13.6M Buy
+297,426
New +$16.7M 0.06% 276

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Acadian Asset Management's ARNA Position: Q3 2020 in Review

Acadian Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 51,546 shares — an estimated $3.25M sold.

Acadian Asset Management first reported a position in ARNA in Q3 2019 and held it in 2 quarters. The position peaked at $13.6M in Q3 2019. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • Acadian Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Acadian Asset Management sold 51,546 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $3.25M.
  • Acadian Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 2 quarters.
  • Acadian Asset Management's Arena Pharmaceuticals Inc position peaked at $13.6M in Q3 2019.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Acadian Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.